By CAFMI AI From JAMA
Myocarditis, an inflammatory disease of the heart muscle, carries a variable long-term prognosis influenced by factors such as age, severity, and underlying health. Some patients recover fully, while others may develop chronic cardiac dysfunction or complications like heart failure and arrhythmias. Long-term monitoring is essential to detect and manage these risks appropriately.
Diagnosing myocarditis is difficult due to its diverse symptoms and lack of a single definitive test. Advanced imaging, biomarkers, and biopsy are used to confirm diagnosis and assess severity. Continuous monitoring with echocardiography, cardiac MRI, and rhythm assessments helps detect early deterioration, guiding timely treatment adjustments to reduce complications.
Healthcare providers must recognize myocarditis as a heterogeneous condition requiring individualized assessment and follow-up. Educating patients on the variable disease course and ensuring adherence to monitoring can improve outcomes. Personalized treatment including medical therapy and lifestyle modifications is recommended, along with multidisciplinary collaboration to manage risk and improve quality of life.
Read The Original Publication Here